(Q39375010)

11 September 2017

BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

Bacon (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients (English)

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

author name string

R. B. Livingston

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

W. H. Fee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

L. H. Einhorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

M. A. Burgess

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

E. J. Freireich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

J. A. Gottlieb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

M. O. Farber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A56980

9 April 2022

language of work or name

English

0 references

publication date

1 March 1976

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

1 reference

11 September 2017

37

1 reference

11 September 2017

1237-1242

1 reference

11 September 2017

3

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

Bronchogenic carcinoma. Factors in survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

In vivo and in vitro studies on cell kinetics and synchronisation of human tumour cells: their significance in cytostatic tumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197603%2937%3A3%3C1237%3A%3AAID-CNCR2820370302%3E3.0.CO%3B2-Z

21 January 2018

2

31

1218

Barranco

1971

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

9 April 2022

3

33

19

Benjamin

1974

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

8

24

1918

Frei

1964

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Alkylating agents in bronchogenic carcinoma

9 April 2022

9

46

516

Green

1969

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

9 April 2022

COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors

10

0 references

14

36

327

Livingston

1975

1 reference

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

https://api.crossref.org/works/10.1002/1097-0142(197603)37:3%3C1237::AID-CNCR2820370302%3E3.0.CO;2-Z

9 April 2022

Identifiers

10.1002/1097-0142(197603)37:3<1237::AID-CNCR2820370302>3.0.CO;2-Z

1 reference

11 September 2017

1 reference